Company
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.
Annual NHS Reviews Recommended for Women with PMOS to Improve Diagnosis, Monitoring and Long-Term Health Outcomes
A major update in women’s health guidance in the UK is calling for women living with polyendocrine metabolic ovarian syndrome (PMOS) to receive yearly health checks through the NHS. The recommendation comes from draft guidance by the National Institute for Health and Care Excellence (NICE), which says the condition is often underdiagnosed and inconsistently managed.
PMOS, previously known as polycystic ovary syndrome (PCOS), is now understood as a broader condition affecting multiple systems in the body. It is estimated to affect around one in eight women and can lead to fertility challenges as well as long-term metabolic and hormonal complications.
This article breaks down the updated guidance, symptoms, diagnosis challenges, and why annual NHS reviews could change outcomes for millions of women in the UK.
PMOS is a long-term hormonal and metabolic condition that affects the ovaries and other systems in the body. It is now recognised as more complex than previously thought under its former name, PCOS.
Health experts describe PMOS as a condition that can affect fertility, metabolism, skin health, and mental wellbeing. According to NHS information, symptoms may include:
Because symptoms vary widely, many people live with the condition for years before receiving a diagnosis.
The draft guidance from NHS advisors highlights that PMOS is not just a reproductive health condition. It can also increase the risk of long-term illnesses such as type 2 diabetes and cardiovascular disease.
Under the new proposal, women diagnosed with PMOS would be offered annual reviews that cover:
The aim is early intervention rather than reactive treatment after complications develop.
Experts at NICE say this approach could help standardise care across the UK and reduce the number of missed or delayed diagnoses.
One of the biggest concerns highlighted in the guidance is the ongoing delay in diagnosis. Many women report repeated visits to healthcare professionals before getting answers.
Diagnosis typically involves:
However, because awareness varies among healthcare professionals, especially in primary care, diagnosis can take months or even years.
The condition is also more common in women of Black, Asian, and mixed ethnic backgrounds, which NICE says should be considered during assessment.
PMOS does not only affect physical health. It can also have a strong emotional and psychological impact. Many individuals report experiences of anxiety, depression, low self-esteem, and frustration linked to visible symptoms such as weight changes or skin conditions.
Fertility concerns are also a major source of stress for many women living with the condition. Lifestyle changes, fertility treatment, and hormone therapy are commonly used to manage symptoms, although there is currently no cure.
Healthcare professionals emphasise that mental health support should be part of routine care rather than treated separately.
Kelis Bailey, a young woman from the East Midlands, shared her experience of living with symptoms from her teenage years. She described long delays in reaching a diagnosis and repeated interactions with healthcare providers who were not initially familiar with the condition.
She explained that her mental health deteriorated during the worst stages of her symptoms and that not being taken seriously added to her stress.
While she supports the idea of annual checkups, she also believes broader awareness among doctors is equally important so patients can be diagnosed earlier and more accurately.
Her experience reflects a wider pattern reported by many women across the UK who struggle to get clear answers for their symptoms.
Although there is no cure for PMOS, several treatment approaches are available to manage symptoms and reduce health risks. These include:
The updated guidance also states that certain cosmetic procedures, such as laser hair reduction, should not be routinely recommended through NHS funding due to cost-effectiveness considerations.
The proposed changes reflect a growing recognition that PMOS is a lifelong condition requiring ongoing monitoring rather than one time diagnosis and treatment.
By introducing annual reviews, the NHS aims to:
Consultation on the draft guidance is open until August 2026, with final recommendations expected later in the year.
The recommendation for annual NHS checks for women with PMOS represents a significant shift in how the condition is managed in the UK. It highlights the importance of early diagnosis, consistent monitoring, and a more holistic approach to care that includes both physical and mental health.
If implemented, these changes could improve long-term outcomes for millions of women and reduce the burden of undiagnosed or poorly managed symptoms.
This blog is a written summary of a news report. It is intended for informational purposes only and does not provide medical advice. For personal health concerns, diagnosis, or treatment, individuals should consult a qualified healthcare professional or contact the NHS directly.